HomeClinical TopicsCardio-PulmonaryFDA approves new drug for heart failure

FDA approves new drug for heart failure

On July 7, the U.S. Food and Drug Administration (FDA) approved Entresto (sacubitril/valsartan) tablets for the treatment of heart failure. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content

For Nurse Practitioners

Couple talking to NP

Getting Covid Vaccine Won’t Hurt Pregnancy Chances; Getting Covid Could

Couples planning a pregnancy might be relieved to know that getting a Covid vaccine does not hurt their odds of conceiving, according to the...